Benzodiazepine Addiction Treatment
Find Benzodiazepine Addiction Treatment centers across Canada. Browse verified treatment facilities offering evidence-based programs for benzodiazepines addiction.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making decisions about addiction treatment.
Benzodiazepine addiction treatment in Canada provides medically supervised care for individuals dependent on medications such as Ativan, Valium, and Xanax. Benzo withdrawal carries serious risks including seizures, making medical detox essential. Canadian treatment centres offer safe, comprehensive programs for benzodiazepine use disorder recovery.
Understanding Benzodiazepine Addiction
Benzodiazepines (benzos) are prescription medications used to treat anxiety, insomnia, seizures, and muscle spasms. Common examples include alprazolam (Xanax), lorazepam (Ativan), diazepam (Valium), and clonazepam (Klonopin). They work by enhancing the effects of GABA, the brain’s primary inhibitory neurotransmitter, producing calming and sedating effects. While effective when used as prescribed short-term, benzos carry significant risks for physical dependence, addiction, and life-threatening withdrawal.
In Canada, benzodiazepine use is widespread. According to Health Canada, approximately 12% of Canadians aged 15+ used benzodiazepines in the past year, with rates highest among women and older adults. What makes benzos particularly dangerous is that physical dependence can develop even when taking prescribed doses—and stopping abruptly can cause seizures and other life-threatening complications.
Dangerous Withdrawal
Benzodiazepine withdrawal can be life-threatening. Abrupt cessation causes seizures, delirium, severe anxiety, and hallucinations. Medically supervised tapering is essential—never stop taking benzos suddenly without medical guidance.
Warning Signs
- • Taking more than prescribed or “doctor shopping”
- • Needing benzos to feel normal or function
- • Memory problems and cognitive impairment
- • Using benzos with alcohol or opioids (deadly)
- • Anxiety/panic when doses are missed
Prescription Doesn’t Mean Safe
Being prescribed by a doctor doesn’t eliminate addiction risk. Physical dependence develops in 2-4 weeks of daily use—even at therapeutic doses. Long-term use (>3-4 months) is strongly discouraged by medical guidelines.
Benzodiazepine Use in Canada
According to Health Canada and the Canadian Institute for Health Information (CIHI):
- 12% of Canadians aged 15+ used benzodiazepines in the past year
- Women are twice as likely as men to be prescribed benzos
- 20% of seniors aged 65+ use benzodiazepines regularly
- Long-term use (>1 year) affects approximately 3% of the Canadian population
- Benzodiazepines are involved in ~17% of opioid-related deaths in Canada (poly-drug toxicity)
Sources: Health Canada Canadian alcohol and Drugs Survey (2023); CIHI Opioid-Related Harms Report (2024)
How Benzodiazepines Affect the Brain
Benzodiazepines bind to GABA-A receptors in the brain, enhancing the effect of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. This increases chloride ion flow into neurons, making them less excitable and producing:
- Anxiolytic effects: Reduced anxiety and stress
- Sedation: Drowsiness and calm
- Muscle relaxation: Reduced tension and spasms
- Anticonvulsant effects: Prevention of seizures
- Amnesia: Impaired memory formation (anterograde amnesia)
The problem: The brain adapts to chronic benzodiazepine exposure by downregulating GABA receptors and altering neurotransmitter balance. This creates tolerance (needing higher doses for the same effect) and physical dependence (requiring the drug to maintain normal brain function). When benzos are stopped, GABA activity plummets while excitatory neurotransmitters surge—causing seizures, anxiety, insomnia, and potentially fatal complications.
Health Risks of Benzodiazepine Use
Short-Term Risks
- • Cognitive impairment: Memory problems, confusion, poor judgment
- • Motor impairment: Coordination problems, increased fall risk (especially elderly)
- • Respiratory depression: Especially when combined with alcohol or opioids (often fatal)
- • Paradoxical reactions: Agitation, aggression, disinhibition (rare but serious)
- • Overdose: Severe sedation, coma, death (risk multiplied by alcohol/opioids)
Long-Term Consequences
- • Cognitive decline: Persistent memory and attention deficits
- • Dementia risk: Studies link long-term use to increased Alzheimer’s risk
- • Depression: Benzos worsen depression long-term despite short-term relief
- • Tolerance: Requiring higher doses, losing therapeutic benefit
- • Physical dependence: Withdrawal symptoms when stopping
Poly-Drug Danger: Benzos + Opioids = Death
Combining benzodiazepines with opioids, alcohol, or other sedatives is extremely dangerous and often fatal. Both drug classes suppress breathing—combined, they amplify respiratory depression exponentially.
- • In Canada, benzos are involved in ~17% of opioid overdose deaths
- • Respiratory depression from this combination can occur even at therapeutic doses
- • Many overdose victims didn’t know they were taking counterfeit pills containing both fentanyl and benzos
Never combine benzodiazepines with opioids, alcohol, or other sedatives without explicit physician supervision.
Benzodiazepine Withdrawal: Why Medical Supervision is Critical
Benzodiazepine withdrawal is one of the most dangerous drug withdrawals—potentially more dangerous than opioid withdrawal. Unlike opioids (uncomfortable but rarely life-threatening), benzo withdrawal can cause:
- Seizures: Grand mal seizures that can be fatal
- Delirium: Confusion, hallucinations, disorientation
- Severe anxiety and panic: Often worse than original symptoms
- Insomnia: Profound sleep disturbance
- Perceptual disturbances: Hypersensitivity to light, sound, touch
- Protracted withdrawal: Symptoms lasting months to years in some cases
The Ashton Protocol: Safe Tapering
The Ashton Manual is the gold-standard protocol for benzodiazepine withdrawal, developed by Professor Heather Ashton at Newcastle University. Key principles:
- Slow taper: Reduce dose by 5-10% every 1-2 weeks (not 25% weekly)
- Switch to long-acting benzo: Convert to diazepam (Valium) for smoother taper
- Individualized pace: Some patients need 6-12+ months to safely taper
- Medical monitoring: Regular check-ins to manage symptoms and adjust taper
- Supportive care: Counseling, stress management, sleep hygiene
Critical: Never attempt to quit benzodiazepines “cold turkey” on your own. Work with a physician experienced in benzo withdrawal—ideally an addiction medicine specialist or psychiatrist.
Treatment for Benzodiazepine Addiction
There are no FDA-approved medications specifically for benzodiazepine use disorder. Treatment focuses on medically supervised tapering, behavioral therapy, and symptom management. The taper process itself IS the medical treatment—done properly, it allows the brain to readjust gradually and safely.
Comprehensive Treatment Approach
Medical Assessment & Stabilization
Comprehensive evaluation of dosage, duration of use, co-occurring conditions, and withdrawal risk. If using high doses or multiple benzos, initial stabilization on a consistent dose before beginning taper.
Medically Supervised Taper (Ashton Protocol)
Gradual dose reduction over weeks to months, typically using diazepam (long half-life) as taper medication. Pace is individualized—rushing increases failure rate and health risks.
- Short-term use (<3 months): Taper over 2-4 weeks
- Long-term use (>6 months): Taper over 2-6 months minimum
- High-dose or long-duration: May require 12+ months for safe taper
Symptom Management
Non-addictive medications and interventions for withdrawal symptoms: SSRIs for anxiety/depression, anticonvulsants for seizure prevention (in severe cases), sleep hygiene for insomnia. Avoid replacing benzos with other addictive substances.
Cognitive Behavioral Therapy (CBT)
Address underlying anxiety, develop non-pharmacological coping strategies, manage withdrawal symptoms psychologically. CBT is the most evidence-based therapy for anxiety disorders—helping prevent benzo relapse long-term.
Ongoing Support & Relapse Prevention
Support groups, continued therapy, stress management techniques. Many patients benefit from 12-step programs or benzo-specific support groups. Ongoing psychiatric care for underlying anxiety/sleep disorders using non-benzo treatments.
Alternatives to Benzodiazepines for Anxiety & Insomnia
Long-term benzodiazepine use is strongly discouraged by medical guidelines. Safer, more effective alternatives exist:
For Anxiety Disorders
- • SSRIs/SNRIs: First-line medications (sertraline, escitalopram, venlafaxine)
- • Buspirone: Non-addictive anxiolytic (slower onset but effective)
- • Cognitive Behavioral Therapy: Gold-standard treatment, lasting results
- • Mindfulness/meditation: Evidence-based for anxiety reduction
- • Exercise: Proven anxiolytic effect, no side effects
For Insomnia
- • CBT for Insomnia (CBT-I): Most effective long-term treatment
- • Sleep hygiene: Behavioral changes (consistent schedule, light exposure, etc.)
- • Melatonin: For circadian rhythm issues
- • Trazodone, mirtazapine: Non-benzo sedating antidepressants
- • Avoid: Z-drugs (Ambien, Lunesta) – similar addiction risk to benzos
Sources & References
1. Health Canada. Canadian Alcohol and Drugs Survey (CADS). 2023. canada.ca
2. Canadian Institute for Health Information (CIHI). Opioid-Related Harms in Canada. 2024. cihi.ca
3. Professor C. Heather Ashton. Benzodiazepines: How They Work and How to Withdraw (The Ashton Manual). 2002. benzo.org.uk
4. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Substance Use Disorders. 2024.
5. British Medical Journal. Benzodiazepine Use and Risk of Dementia: Prospective Population Based Study. 2023.
6. Canadian Centre on Substance Use and Addiction (CCSA). Prescription Psychoactive Drugs in Canada. 2024.
7. Substance Abuse and Mental Health Services Administration (SAMHSA). Detoxification and Substance Abuse Treatment. 2024.
8. World Health Organization. Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings. 2023.
Get Help for Benzodiazepine Dependence
If you’ve been taking benzodiazepines regularly—even as prescribed—you may be physically dependent. Do not stop abruptly. Professional medical guidance is essential for safe withdrawal. With proper tapering and support, you can successfully discontinue benzos and regain your life.
Sources & Further Reading
Last reviewed
April 14, 2026
Treatment Centers for Benzodiazepine Addiction
Awakenings Health and Wellness Centre
Awakenings Health and Wellness Centre in Abbotsford offers medically supervised detox, inpatient residential treatment, holistic therapy, and outpatient services for individuals dealing with alcohol, opioid, benzodiazepine, and other substance use disorders in the Fraser Valley.
Charles J. Andrew Healing Centre in Sheshatshiu, Labrador is a CAC-accredited 10-bed Indigenous residential treatment facility offering 12-week adult programs and youth services combining 50% clinical trauma-informed care with 50% Nutshimit land-based healing for Innu and First Nations peoples.
Charlford House in Burnaby is a 15-bed, 90-day residential recovery program for women 19+, offering trauma-informed, abstinence-based treatment using a Surrogate Family Model, Twelve-Step programming, holistic therapies, and aftercare support as part of the Together We Can network.
Cochrane District Detoxification Centre
Cochrane District Detoxification Centre in Smooth Rock Falls, Ontario is a 27-bed residential detox facility offering bilingual, 24/7 withdrawal management with culturally safe programming for northeastern Ontario communities.
Crosbie House in New Minas, NS is a not-for-profit residential addiction centre offering a 4-6 week structured programme with individual and group therapy, family support, holistic care, and on-site gym facilities, with a 75% one-year abstinence rate.
Foothills Detox Centre is an Alberta Health Services medical detoxification facility in Fort Macleod offering clinically supervised withdrawal management for alcohol, opioids, fentanyl, methamphetamine, cocaine, and benzodiazepines.
The Foundation for Youth Support at Fisherman's Memorial Hospital in Lunenburg provides outpatient addiction counselling and medically supervised detoxification for South Shore Nova Scotia residents, addressing alcohol, opioid, benzodiazepine, and other substance use concerns.
iRecover Alberta is a CARF-certified residential addiction treatment centre in Tees, Alberta, offering medically supervised detox, inpatient treatment for a wide range of substances, and a lifetime aftercare program with no referral required.
Kingston Health Sciences Centre’s Detoxification Centre
Kingston Health Sciences Centre's Detoxification Centre is southeastern Ontario's only detox facility, providing free, voluntary, short-stay withdrawal management for individuals 16+ in a safe, clinical environment.
Kwakiutl District Council Health in Campbell River, BC provides First Nations-led outpatient addiction counselling, medical detox support, and holistic health services for Kwakwaka'wakw and Indigenous community members on northern Vancouver Island.
Last Door Adult Program is an Accreditation Canada-certified 90-day residential treatment program for men 19+ in New Westminster, BC, offering medical detox, integrated community social model recovery, Keystone Retreat access, co-occurring disorder treatment, and comprehensive family programming.
Last Door Youth Program is an Accreditation Canada-certified residential treatment program in New Westminster, BC for youth ages 13–25, offering 3-month to 1-year programs with medical detox, outdoor therapy, educational support, and family involvement.
Medical Detox Ontario
Medical Detox Ontario (1000 Islands Addiction Treatment Centre) is a CARF-accredited private facility in the Thousand Islands region offering medically supervised detox and gender-specific addiction treatment.
Metis Addictions Council of Saskatchewan Inc
MACSI (Métis Addictions Council of Saskatchewan) provides culturally responsive residential, medical detox, and outpatient addiction treatment for Métis and other Saskatchewan residents from locations in Prince Albert, Saskatoon, and Regina.
The Native Courtworker and Counselling Association of BC (NCCABC) provides Indigenous outpatient addiction counselling, detox support, and mental health services in North Vancouver and Surrey, delivering culturally safe, trauma-informed care for Indigenous people across the Lower Mainland.
Neworld Medical Detox
Neworld Medical Detox (now Trafalgar Addiction Treatment Centres) in Limehouse, Ontario offers CARF-accredited medical detox and gender-specific residential addiction treatment for alcohol, opioids, and other substances.
Phoenix Centre (Day One Society) in Kamloops provides detoxification services, outpatient addiction counselling, youth and family support, and transitional living programs for individuals navigating substance use recovery in the Thompson-Nicola region of BC.
Robert Simard Centre
Robert Simard Centre in Meadow Lake, Saskatchewan is a Saskatchewan Health Authority voluntary social detoxification unit offering 7–10 day medically supervised withdrawal support for adults in northern Saskatchewan.
Safe Harbour Society
Safe Harbour Society is a Red Deer non-profit offering medically supported detox, outreach, Indigenous Wellbriety programming, and housing support — providing over 20 years of community-centred addiction recovery services in Central Alberta.
Souris Hospital
Souris Hospital (Health PEI) provides publicly funded addiction treatment including medical detox, intensive outpatient, and partial hospitalization programs for residents of eastern Prince Edward Island.
Get Help Now
Speak with an addiction specialist about benzodiazepine addiction treatment treatment options.
+1-877-254-3348Get Support